Gefitinib initiates sterile inflammation by promoting IL-1β and HMGB1 release via two distinct mechanisms.
Cell Death Dis. 2021 Jan 6;12(1):49. doi: 10.1038/s41419-020-03335-7.
Cell Death Dis. 2021.
PMID: 33414419
Free PMC article.